(Z)-3-(1-hydroxypropylidene)-2-oxo-1-propionylindoline-6-car...
|
Impurity |
CS-O-44850 |
Not Available |
Enquire |
(Z)-4-(2-((4-(((6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)(...
|
Impurity |
CS-O-37559 |
1799894-54-4 |
Enquire |
(Z)-methyl 3- (1-methoxypropylidene)-2-oxo-1-propionylindoli...
|
Impurity |
CS-O-44851 |
Not Available |
Enquire |
2-Chloro-N-Methyl-N-(4-Nitrophenyl)Acetamide
|
Impurity |
CS-O-16027 |
2653-16-9 |
In Stock |
3-(Methoxy-phenyl-methylene)2-oxo-1-propionyl-2,3-dihydro-1H...
|
Impurity |
CS-O-44852 |
Not Available |
Enquire |
Dimethyl 2-(4-(methoxycarbonyl)-2-nitrophenyl)malonate
|
Impurity |
CS-O-16116 |
1160293-27-5 |
In Stock |
Methyl (Z)-3-((4-(2-((4-((((Z)-6-(methoxycarbonyl)-2-oxoindo...
|
Impurity |
CS-O-59167 |
---- |
Enquire |
N1,N4-Bis(4-nitrophenyl)-1,4-piperazinediacetamide
|
Impurity |
CS-BX-02882 |
294193-70-7 |
In Stock |
N-Acetyl Nintedanib
|
Impurity |
CS-O-32878 |
2380229-45-6 |
Enquire |
N-Desmethyl Nintedanib
|
Impurity |
CS-O-45337 |
334951-61-0 |
In Stock |
Nintedanib 4-Hydroxyphenyl Analog
|
Impurity |
CS-O-54362 |
2519501-85-8 |
Enquire |
Nintedanib Acetamide
|
Impurity |
CS-O-16016 |
262368-25-2 |
In Stock |
Nintedanib acetyl impurity
|
Impurity |
CS-O-32877 |
1139458-48-2 |
In Stock |
Nintedanib E-isomer (Intedanib E-isomer)
|
Impurity |
CS-P-05581 |
Not Available |
Enquire |
Nintedanib Esylate N-Oxide Impurity
|
Impurity |
CS-O-56488 |
---- |
Enquire |
Nintedanib Ethoxy Enolindole
|
Impurity |
CS-O-34295 |
656247-19-7 |
Enquire |
Nintedanib Ethoxyenolindole
|
Impurity |
CS-O-45336 |
2095628-43-4 |
Enquire |
Nintedanib Ethyl Ester
|
Impurity |
CS-O-46562 |
Not Available |
Enquire |
Nintedanib Impurity 12
|
Impurity |
CS-O-56593 |
---- |
Enquire |
Nintedanib Impurity 13
|
Impurity |
CS-O-56594 |
---- |
Enquire |
Nintedanib Impurity 16
|
Impurity |
CS-O-56595 |
---- |
Enquire |
Nintedanib Impurity 17
|
Impurity |
CS-O-56596 |
---- |
Enquire |
Nintedanib Impurity 18
|
Impurity |
CS-O-56597 |
2936656-87-8 |
Enquire |
Nintedanib Impurity 22
|
Impurity |
CS-O-42675 |
2410284-89-6 |
In Stock |
Nintedanib Impurity 25
|
Impurity |
CS-EO-00266 |
---- |
Enquire |
Nintedanib Impurity 26
|
Impurity |
CS-EO-01297 |
Not Available |
In Stock |
Nintedanib Impurity 28
|
Impurity |
CS-SN-00148 |
2410649-54-4 |
In Stock |
Nintedanib Impurity 4
|
Impurity |
CS-P-01886 |
1987887-92-2 |
Enquire |
Nintedanib Impurity 4 TFA salt
|
Impurity |
CS-O-53559 |
1987887-92-2(free base) |
In Stock |
Nintedanib Impurity 43
|
Impurity |
CS-EO-02111 |
856844-57-0 |
In Stock |
Nintedanib Impurity 5
|
Impurity |
CS-P-01887 |
Not Available |
In Stock |
Nintedanib Impurity 53
|
Impurity |
CS-EO-02746 |
676326-36-6 |
In Stock |
Nintedanib Impurity 54
|
Impurity |
CS-EO-02747 |
1175365-43-1 |
Enquire |
Nintedanib Impurity 63
|
Impurity |
CS-P-09212 |
2243384-71-4 |
Enquire |
Nintedanib Impurity 8
|
Impurity |
CS-P-01890 |
2093243-16-2 |
Enquire |
Nintedanib Impurity B
|
Impurity |
CS-P-01876 |
894783-61-0 |
In Stock |
Nintedanib Impurity E
|
Impurity |
CS-P-01879 |
1610881-60-1 |
Enquire |
Nintedanib Impurity H
|
Impurity |
CS-P-01882 |
Not Available |
Enquire |
Nintedanib Impurity H
|
Impurity |
CS-O-46561 |
2734676-68-5 |
Enquire |
Nintedanib Methyl impurity
|
Impurity |
CS-O-32876 |
2734410-06-9 |
Enquire |
Nintedanib N, N-Dimethyl amine impurity
|
Impurity |
CS-O-45335 |
2454314-41-9 |
In Stock |
Nintedanib N-Acetyl Impurity
|
Impurity |
CS-EO-01565 |
2130844-77-6 |
Enquire |
Nintedanib N-Acyl methoxyenolindole
|
Impurity |
CS-O-60139 |
1253769-13-9 |
Enquire |
Nintedanib N-desmethyl N-ethyl Impurity
|
Impurity |
CS-O-41234 |
---- |
In Stock |
Nintedanib N-Oxide Impurity 1
|
Impurity |
CS-O-41346 |
---- |
In Stock |
Nintedanib N-oxide Impurity H
|
Impurity |
CS-O-53558 |
---- |
Enquire |
Nintedanib Piperazine Dimer Acetyl Impurity
|
Impurity |
CS-O-56489 |
2410649-55-5 |
Enquire |
Nintedanib Piperazine Dimer Impurity
|
Impurity |
CS-EO-01904 |
2410284-90-9 |
Enquire |
Nintedanib Piperazinyl-N4-oxide
|
Impurity |
CS-O-35713 |
3029792-02-4 |
Enquire |
N-Propanoyl Nintedanib
|
Impurity |
CS-O-45007 |
2097505-01-4 |
Enquire |